Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
CAT# | 10-101-59 |
Chemical Structure | ![]() |
CAS | 204656-20-2 |
M.F/Formula | C172H265N43O51 |
M.W/Mr. | 3751.2 |
Sequence | One Letter Code: HAEGTFTSDVSSYL-{N6-[N-(1-oxohexadecyl)-L-γ-Etamyl]-Glu}-GQAAKEFIAWLVRGRG Three Letter Code: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-{N6-[N-(1-oxohexadecyl)-L-γ-Glutamyl]-Glu}-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
Storage | Desiccate at -20°C | Solubility | H2O : 5 mg/mL (1.33 mM; ultrasonic and adjust pH to 8 with NaOH) | Shipping Condition | Room temperature in continental US; may vary elsewhere. |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-158 | Albiglutide | Inquiry | ||
10-101-159 | Dulaglutide | Inquiry | ||
10-101-28 | Pramlintide | Inquiry |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).